drugset / Trial / NCT02443285
Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?
RandomizedParallel-groupDouble-blindTreatment
Summary
Current European and most other international guidelines recommend the use of a third-generation cephalosporin as the first choice, or amoxicillin-clavulanate acid or fluoroquinolones as an alternative choice . These recommendations are based mainly on clinical trials that were very often conducted a decade or more ago, and on the assumption that E. coli would be involved in nearly half of the cases. The microbial etiology of SBP remains relatively constant; however, the antibiotic resistance rate especially for third-generation cephalosporins (including cefotaxime and ceftazidime), ciprofloxacin, and ofloxacin increased dramatically .
Timeline
- Start
- 2015-01
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cefotaxime | Small molecule | 2 g | — |
| Comparator | Ceftriaxone | Other / unclassified | 2 g | — |